Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Paraventricular Hypothalamic Nucleus | 14 | 2024 | 58 | 4.830 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 12 | 2023 | 147 | 3.280 |
Why?
|
| Hypertension | 13 | 2023 | 1274 | 3.220 |
Why?
|
| Neurons | 13 | 2024 | 1918 | 1.960 |
Why?
|
| Excitatory Postsynaptic Potentials | 8 | 2024 | 129 | 1.920 |
Why?
|
| Hypothalamus | 9 | 2023 | 213 | 1.770 |
Why?
|
| Receptors, AMPA | 2 | 2024 | 49 | 1.700 |
Why?
|
| Sympathetic Nervous System | 7 | 2023 | 62 | 1.380 |
Why?
|
| Calcineurin Inhibitors | 3 | 2024 | 28 | 1.300 |
Why?
|
| Tacrolimus | 3 | 2024 | 98 | 1.300 |
Why?
|
| Rats | 15 | 2024 | 3657 | 1.200 |
Why?
|
| Pituitary-Adrenal System | 2 | 2018 | 37 | 1.150 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2018 | 65 | 1.140 |
Why?
|
| Calcineurin | 2 | 2024 | 100 | 1.080 |
Why?
|
| Blood Pressure | 5 | 2023 | 1314 | 1.070 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2024 | 1213 | 1.060 |
Why?
|
| Calcium Channels, L-Type | 2 | 2021 | 53 | 0.900 |
Why?
|
| Rats, Inbred WKY | 8 | 2023 | 54 | 0.770 |
Why?
|
| Rats, Inbred SHR | 8 | 2023 | 64 | 0.760 |
Why?
|
| Gene-Environment Interaction | 1 | 2021 | 118 | 0.720 |
Why?
|
| Stress, Psychological | 4 | 2021 | 555 | 0.710 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2020 | 43 | 0.690 |
Why?
|
| Glutamic Acid | 2 | 2020 | 200 | 0.690 |
Why?
|
| Presynaptic Terminals | 1 | 2020 | 76 | 0.680 |
Why?
|
| Orexin Receptors | 1 | 2019 | 1 | 0.670 |
Why?
|
| Vasomotor System | 1 | 2019 | 25 | 0.660 |
Why?
|
| Ion Channels | 1 | 2020 | 187 | 0.650 |
Why?
|
| KCNQ Potassium Channels | 1 | 2016 | 6 | 0.560 |
Why?
|
| Animals | 22 | 2024 | 33721 | 0.560 |
Why?
|
| Stress, Physiological | 1 | 2018 | 265 | 0.510 |
Why?
|
| Hippocampus | 2 | 2020 | 811 | 0.500 |
Why?
|
| Patch-Clamp Techniques | 4 | 2020 | 277 | 0.500 |
Why?
|
| Corticotropin-Releasing Hormone | 4 | 2018 | 58 | 0.450 |
Why?
|
| Membrane Proteins | 1 | 2020 | 1520 | 0.410 |
Why?
|
| Solute Carrier Family 12, Member 2 | 2 | 2023 | 7 | 0.360 |
Why?
|
| Obesity | 1 | 2019 | 2083 | 0.310 |
Why?
|
| Synapses | 2 | 2024 | 447 | 0.290 |
Why?
|
| Male | 16 | 2024 | 59522 | 0.240 |
Why?
|
| DNA Demethylation | 1 | 2023 | 7 | 0.230 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2023 | 60 | 0.220 |
Why?
|
| Aspartic Acid | 1 | 2023 | 75 | 0.220 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2020 | 30 | 0.220 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2022 | 4 | 0.210 |
Why?
|
| Corticosterone | 3 | 2017 | 61 | 0.210 |
Why?
|
| Organ Culture Techniques | 2 | 2020 | 155 | 0.210 |
Why?
|
| N-Methylaspartate | 1 | 2022 | 29 | 0.210 |
Why?
|
| Posterior Horn Cells | 1 | 2021 | 6 | 0.200 |
Why?
|
| Theta Rhythm | 1 | 2021 | 25 | 0.200 |
Why?
|
| Calcium Channels | 2 | 2018 | 159 | 0.180 |
Why?
|
| Nestin | 1 | 2020 | 17 | 0.180 |
Why?
|
| Neuroendocrine Tumors | 1 | 2021 | 52 | 0.180 |
Why?
|
| Microinjections | 1 | 2020 | 53 | 0.180 |
Why?
|
| Propionates | 1 | 2020 | 30 | 0.180 |
Why?
|
| Long-Term Potentiation | 1 | 2021 | 162 | 0.180 |
Why?
|
| Spinal Cord | 1 | 2021 | 301 | 0.170 |
Why?
|
| Orexins | 1 | 2019 | 5 | 0.170 |
Why?
|
| Telemetry | 1 | 2019 | 27 | 0.170 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2020 | 72 | 0.170 |
Why?
|
| Rats, Zucker | 1 | 2019 | 41 | 0.170 |
Why?
|
| Calcium | 1 | 2024 | 1095 | 0.160 |
Why?
|
| Neuronal Plasticity | 1 | 2021 | 274 | 0.160 |
Why?
|
| Arterial Pressure | 1 | 2019 | 103 | 0.160 |
Why?
|
| Pain | 1 | 2021 | 450 | 0.160 |
Why?
|
| Gene Silencing | 1 | 2019 | 236 | 0.160 |
Why?
|
| Hypoxia | 1 | 2020 | 246 | 0.150 |
Why?
|
| Peptides | 1 | 2022 | 798 | 0.150 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2024 | 532 | 0.150 |
Why?
|
| Mice, Knockout | 3 | 2021 | 3770 | 0.150 |
Why?
|
| Adrenergic Fibers | 1 | 2017 | 4 | 0.150 |
Why?
|
| Mice | 4 | 2023 | 17546 | 0.150 |
Why?
|
| Renin-Angiotensin System | 1 | 2018 | 95 | 0.150 |
Why?
|
| Behavior, Animal | 1 | 2020 | 476 | 0.150 |
Why?
|
| Receptors, GABA-B | 1 | 2017 | 17 | 0.150 |
Why?
|
| Neuropeptide Y | 1 | 2017 | 36 | 0.140 |
Why?
|
| Receptors, Ghrelin | 1 | 2017 | 28 | 0.140 |
Why?
|
| Angiotensin II | 1 | 2018 | 161 | 0.140 |
Why?
|
| Ghrelin | 1 | 2017 | 47 | 0.140 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 663 | 0.140 |
Why?
|
| Adenylate Kinase | 1 | 2016 | 11 | 0.140 |
Why?
|
| KCNQ3 Potassium Channel | 1 | 2016 | 19 | 0.140 |
Why?
|
| Down-Regulation | 1 | 2019 | 702 | 0.140 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2017 | 168 | 0.140 |
Why?
|
| Heart Rate | 1 | 2019 | 584 | 0.140 |
Why?
|
| src-Family Kinases | 1 | 2016 | 83 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 1679 | 0.130 |
Why?
|
| Protein Subunits | 1 | 2016 | 164 | 0.130 |
Why?
|
| Brain Ischemia | 1 | 2018 | 258 | 0.130 |
Why?
|
| Casein Kinase I | 1 | 2015 | 12 | 0.130 |
Why?
|
| Glucose | 1 | 2020 | 875 | 0.130 |
Why?
|
| Neural Inhibition | 1 | 2016 | 105 | 0.130 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2016 | 165 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 689 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 4366 | 0.110 |
Why?
|
| Brain Injuries | 1 | 2018 | 759 | 0.100 |
Why?
|
| Brain | 1 | 2023 | 2937 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 3050 | 0.090 |
Why?
|
| Stroke | 1 | 2018 | 957 | 0.090 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 1 | 2021 | 19 | 0.050 |
Why?
|
| Sciatic Nerve | 1 | 2021 | 56 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 398 | 0.050 |
Why?
|
| Proteomics | 1 | 2024 | 475 | 0.040 |
Why?
|
| Female | 3 | 2021 | 64883 | 0.040 |
Why?
|
| Incidental Findings | 1 | 2021 | 123 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 548 | 0.040 |
Why?
|
| Tetrazolium Salts | 1 | 2018 | 15 | 0.040 |
Why?
|
| DNA | 1 | 2023 | 1606 | 0.040 |
Why?
|
| Agouti-Related Protein | 1 | 2017 | 41 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2023 | 2826 | 0.040 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2017 | 44 | 0.040 |
Why?
|
| Neuroprotective Agents | 1 | 2018 | 150 | 0.030 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2016 | 7 | 0.030 |
Why?
|
| Bumetanide | 1 | 2016 | 7 | 0.030 |
Why?
|
| Muscimol | 1 | 2016 | 9 | 0.030 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2017 | 90 | 0.030 |
Why?
|
| GABA-A Receptor Agonists | 1 | 2016 | 6 | 0.030 |
Why?
|
| Humans | 4 | 2024 | 122296 | 0.030 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2016 | 31 | 0.030 |
Why?
|
| Receptors, GABA-A | 1 | 2016 | 58 | 0.030 |
Why?
|
| Pyridazines | 1 | 2016 | 49 | 0.030 |
Why?
|
| Eating | 1 | 2017 | 355 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2016 | 304 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2016 | 1104 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2016 | 873 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 2030 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 2441 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 4282 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 25640 | 0.010 |
Why?
|